NEW YORK – RNA research firm Eclipse Bioinnovations is working to expand its assay portfolio and drive adoption of its eCLIP method for studying RNA-protein binding.
The company is also increasing its capabilities around analyzing modified forms of RNA, which is an area of growing interest among cancer drug developers, said Gene Yeo, professor of cellular and molecular medicine at the University of California, San Diego and developer of the eCLIP technique.